Table 1 Characteristics of the studies eligible for current meta-analysis
Author | Year | Country | Ethnicity | Case | Control | SOC | Cases | Controls | HWE | Genotype | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MM | MW | WW | MM | MW | WW | |||||||||
rs1800629 | ||||||||||||||
Jones | 2013 | USA | African-American | 279 | 535 | HB | 5 | 103 | 171 | 14 | 153 | 368 | 0.687 | Illumina’s Golden gate |
Zabaleta | 2008 | USA | African-American | 67 | 130 | HB | 2 | 9 | 56 | 3 | 33 | 94 | 0.958 | Sequence |
Berhane | 2012 | India | Asian | 150 | 150 | HB | 6 | 24 | 120 | 1 | 18 | 131 | 0.662 | ARMS-PCR |
Wu | 2003 | China-Taiwan | Asian | 96 | 126 | HB | 2 | 20 | 74 | 1 | 22 | 103 | 0.882 | PCR-RFLP |
Alidoost | 2019 | Iran | Asian | 100 | 110 | HB | 0 | 16 | 84 | 0 | 14 | 96 | 0.476 | PCR-RFLP/ARMS-PCR |
Kesarwani | 2009 | India | Asian | 197 | 256 | HB | 1 | 21 | 175 | 4 | 37 | 215 | 0.115 | PCR-RFLP |
Ali | 2019 | Iraq | Asian | 30 | 30 | PB | 12 | 18 | 0 | 24 | 6 | 0 | 0.543 | PCR-RFLP |
Ge | 2007 | China | Asian | 245 | 245 | HB | 2 | 39 | 204 | 2 | 48 | 195 | 0.609 | TaqMan |
Dluzniewski | 2012 | USA | Caucasian | 468 | 468 | HB | 14 | 113 | 341 | 6 | 126 | 336 | 0.125 | MassArray |
Pardo | 2019 | Venezuela | Caucasian | 40 | 40 | HB | 0 | 6 | 34 | 0 | 11 | 29 | 0.313 | PCR-RFLP |
Zabaleta | 2008 | USA | Caucasian | 479 | 400 | HB | 9 | 148 | 322 | 10 | 118 | 272 | 0.505 | Sequence |
Sáenz-López | 2008 | Spain | Caucasian | 296 | 310 | PB | 5 | 70 | 221 | 2 | 52 | 256 | 0.714 | TaqMan |
Moore | 2009 | USA | Caucasian | 949 | 857 | PB | 21 | 228 | 700 | 11 | 205 | 641 | 0.231 | TaqMan |
Danforth | 2008 | USA | Caucasian | 1155 | 1380 | PB | 26 | 336 | 793 | 45 | 418 | 926 | 0.795 | TaqMan/MGBEclipse assay |
Danforth | 2008 | USA | Caucasian | 1111 | 1125 | PB | 25 | 294 | 792 | 33 | 286 | 806 | 0.217 | TaqMan/MGBEclipse assay |
Ribeiro | 2012 | Portugal | Caucasian | 449 | 557 | PB | 8 | 115 | 326 | 7 | 143 | 407 | 0.155 | TaqMan |
Wang | 2009 | USA | Caucasian | 251 | 250 | PB | 12 | 79 | 160 | 9 | 69 | 172 | 0.529 | TaqMan |
Bandil | 2017 | India | Asian | 105 | 115 | HB | 9 | 15 | 81 | 4 | 7 | 104 | < 0.001 | ARMS-PCR |
Omrani | 2008 | Iran | Asian | 41 | 105 | HB | 0 | 36 | 5 | 3 | 99 | 3 | < 0.001 | ASO-PCR |
McCarron | 2002 | United Kingdom | Caucasian | 239 | 220 | HB | 6 | 66 | 167 | 13 | 57 | 150 | 0.023 | ARMS-PCR |
OH | 2000 | USA | Caucasian | 73 | 73 | HB | 0 | 53 | 20 | 0 | 53 | 20 | < 0.001 | allele-specific PCR |
Zhang | 2010 | USA | Caucasian | 116 | 128 | PB | 116 | 128 | CBMALD-TOF-MS | |||||
rs361525 | ||||||||||||||
Pardo | 2019 | Venezuela | Caucasian | 40 | 40 | HB | 0 | 4 | 36 | 0 | 1 | 39 | 0.936 | PCR-RFLP |
OH | 2000 | USA | Caucasian | 73 | 73 | HB | 0 | 23 | 50 | 0 | 23 | 50 | 0.11 | allele-specific PCR |
Zabaleta | 2008 | USA | Caucasian | 471 | 385 | HB | 6 | 41 | 424 | 0 | 39 | 346 | 0.295 | Sequence |
Alidoost | 2019 | Iran | Asian | 100 | 110 | HB | 0 | 10 | 90 | 0 | 5 | 105 | 0.807 | PCR-RFLP/ARMS-PCR |
Danforth | 2008 | USA | Caucasian | 1114 | 1126 | PB | 1 | 121 | 992 | 3 | 100 | 1023 | 0.737 | TaqMan/MGBEclipse assay |
Ge | 2007 | China | Asian | 245 | 245 | HB | 0 | 10 | 235 | 0 | 22 | 223 | 0.461 | TaqMan |
Zabaleta | 2008 | USA | African-American | 64 | 126 | HB | 0 | 6 | 58 | 2 | 10 | 114 | 0.006 | Sequence |
Bandil | 2017 | India | Asian | 105 | 115 | HB | 12 | 60 | 33 | 20 | 86 | 9 | < 0.001 | ARMS-PCR |
rs1799724 | ||||||||||||||
Danforth | 2008 | USA | Caucasian | 1139 | 1378 | PB | 13 | 203 | 923 | 14 | 254 | 1110 | 0.9 | TaqMan/MGBEclipse assay |
Danforth | 2008 | USA | Caucasian | 1108 | 1101 | PB | 17 | 183 | 908 | 19 | 220 | 862 | 0.257 | TaqMan/MGBEclipse assay |
Kesarwani | 2009 | India | Asian | 197 | 256 | HB | 4 | 57 | 136 | 4 | 56 | 196 | 1 | PCR-RFLP |
Zabaleta | 2008 | USA | African-American | 464 | 372 | HB | 6 | 59 | 399 | 8 | 41 | 323 | < 0.001 | Sequence |
Zabaleta | 2008 | USA | Caucasian | 6 | 14 | HB | 3 | 0 | 3 | 7 | 0 | 7 | < 0.001 | Sequence |
rs1799964 | ||||||||||||||
Danforth | 2008 | USA | Caucasian | 1142 | 1375 | PB | 60 | 361 | 721 | 58 | 441 | 876 | 0.791 | TaqMan/MGBEclipse assay |
Danforth | 2008 | USA | Caucasian | 1143 | 1155 | PB | 54 | 370 | 719 | 64 | 377 | 714 | 0.129 | TaqMan/MGBEclipse assay |
Kesarwani | 2009 | India | Asian | 197 | 256 | HB | 90 | 64 | 43 | 83 | 91 | 82 | < 0.001 | PCR-RFLP |